Conserved Aging Mechanisms Impacting Dopamine Neuron Survival

影响多巴胺神经元存活的保守衰老机制

基本信息

  • 批准号:
    10351123
  • 负责人:
  • 金额:
    $ 23.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-08-04 至 2024-04-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY The single biggest risk factor for developing Parkinson’s disease is age, suggesting that age-related changes in the brain predispose to loss of dopamine (DA) neuron health and viability. Cell stressors such as oxidative stress and metabolic dysfunction increase with age in many species including humans, and DA neurons are particularly vulnerable to oxidative stress because of their high metabolic demands and intrinsic reactive oxygen species production. Despite a growing body of evidence linking elevated oxidative stress to aging and DA neuron degeneration, the role of oxidative stress-responsive signaling pathways in connecting this stress to enhanced DA neuron vulnerability with age are not well understood. Prior studies link activation of the HIF-1 (hypoxia-inducible factor-1) pathway to suppression of TOR (target of rapamycin) signaling and recent GWAS studies raise the possibility that the interaction of these pathways may be important in regulating lifespan, possibly in response to cellular stress signals. Key components of HIF-1/TOR signaling are also altered in human Parkinson’s disease substantia nigra DA neurons. The primary goal of this proposal is to determine whether age-related oxidative stress results in sustained upregulation of specific signaling mediators in the HIF-1/TOR signaling pathway that promote susceptibility of DA neurons to age- related death and limit organismal lifespan. Studies from multiple animal models including Drosophila indicate that TOR deregulation is a feature of nervous system aging and neurodegenerative disease. We will leverage the natural genetic variation in a collection of Drosophila genetic backgrounds that we find influences reactive oxygen species production, lifespan and DA neuron viability to achieve two primary goals: First, we will examine the effects of aging on brain expression of oxidative stress signaling mediators both in the whole brain as well as in specific vulnerable (i.e. DA) and spared neuronal populations. Second, we will determine the role of these signaling mediators on age-related DA neuron death and lifespan. These exploratory studies will pave the way for detailed characterization of how aging and age-related stress drives upstream regulators of this signaling pathway, and inform broader studies on the role of these signaling mediators in Parkinson’s disease neurodegeneration linked to additional genetic and environmental factors.
项目总结 患帕金森氏症的最大风险因素是年龄,这表明与年龄有关的 大脑的变化容易导致多巴胺(DA)神经元的健康和活性丧失。细胞应激源 如氧化应激和代谢功能障碍等在许多物种中随着年龄的增长而增加,包括 人类和DA神经元特别容易受到氧化应激的影响,因为它们的 代谢需求和内源性活性氧的产生。尽管越来越多的 氧化应激增加与衰老和DA神经元变性有关的证据,氧化的作用 将这种应激与增强的DA神经元脆弱性联系起来的应激反应信号通路 随着年龄的增长,人们对此还没有很好的理解。先前的研究将HIF-1(缺氧诱导因子-1)的激活联系起来 抑制TOR(雷帕霉素靶标)信号的途径和最近的GWAS研究提高了 这些通路的相互作用在调节寿命方面可能很重要,可能在 对细胞应激信号的反应。HIF-1/TOR信号的关键组件也在 人帕金森病黑质DA神经元。这项提议的主要目标是 确定与年龄相关的氧化应激是否导致特定信号的持续上调 HIF-1/TOR信号通路中促进DA神经元对AGE易感性的介体 相关死亡和限制生物寿命。包括果蝇在内的多种动物模型的研究 提示TOR去调控是神经系统老化和神经退行性疾病的一个特征。 我们将利用果蝇遗传背景集合中的自然遗传变异 我们发现影响活性氧产生、寿命和DA神经元活性的因素 两个主要目标:首先,我们将研究衰老对大脑氧化应激表达的影响 在整个大脑中以及在特定的脆弱(即DA)和备用的信号媒介 神经元群。第二,我们将确定这些信号中介在与年龄相关的 DA神经元死亡和寿命。这些探索性研究将为详细的 衰老和与年龄相关的压力如何驱动该信号的上游调节因子的特征 途径,并为有关这些信号介质在帕金森病中的作用的更广泛的研究提供信息 神经退化与额外的遗传和环境因素有关。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ian Martin其他文献

Ian Martin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ian Martin', 18)}}的其他基金

LRRK2 in Parkinson's Disease Neurodegeneration
LRRK2 在帕金森病神经变性中的作用
  • 批准号:
    10546462
  • 财政年份:
    2022
  • 资助金额:
    $ 23.1万
  • 项目类别:
LRRK2 in Parkinson's Disease Neurodegeneration
LRRK2 在帕金森病神经变性中的作用
  • 批准号:
    10363330
  • 财政年份:
    2022
  • 资助金额:
    $ 23.1万
  • 项目类别:
Conserved Aging Mechanisms Impacting Dopamine Neuron Survival
影响多巴胺神经元存活的保守衰老机制
  • 批准号:
    10676085
  • 财政年份:
    2022
  • 资助金额:
    $ 23.1万
  • 项目类别:
Role of Elevated Diet-linked TOR Activity and Protein Synthesis in Parkinson's Disease Neurodegeneration
饮食相关的 TOR 活性和蛋白质合成升高在帕金森病神经变性中的作用
  • 批准号:
    8948116
  • 财政年份:
    2015
  • 资助金额:
    $ 23.1万
  • 项目类别:
Role of Elevated Diet-linked TOR Activity and Protein Synthesis in Parkinson's Disease Neurodegeneration
饮食相关的 TOR 活性和蛋白质合成升高在帕金森病神经变性中的作用
  • 批准号:
    9134565
  • 财政年份:
    2015
  • 资助金额:
    $ 23.1万
  • 项目类别:

相似海外基金

Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10506915
  • 财政年份:
    2021
  • 资助金额:
    $ 23.1万
  • 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10325006
  • 财政年份:
    2021
  • 资助金额:
    $ 23.1万
  • 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
  • 批准号:
    1746198
  • 财政年份:
    2018
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
  • 批准号:
    512537-2017
  • 财政年份:
    2017
  • 资助金额:
    $ 23.1万
  • 项目类别:
    University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
  • 批准号:
    1404605
  • 财政年份:
    2014
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
  • 批准号:
    1263713
  • 财政年份:
    2013
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
  • 批准号:
    425749-2012
  • 财政年份:
    2012
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
  • 批准号:
    1159886
  • 财政年份:
    2012
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
  • 批准号:
    19560760
  • 财政年份:
    2007
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
  • 批准号:
    234753-2000
  • 财政年份:
    2003
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Collaborative Research and Development Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了